These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 28534369

  • 1. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
    Gong J, He L, Ma J, Zhang J, Wang L, Wang J.
    J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
    [Abstract] [Full Text] [Related]

  • 2. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.
    Hu Y, Qin X, Yan D, Cao H, Zhou L, Fan F, Zang J, Ni J, Xu X, Sha H, Liu S, Yu S, Wu J, Ma R, Feng J.
    Tumour Biol; 2017 Mar; 39(3):1010428317691659. PubMed ID: 28345454
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, Peng Y, Cao J.
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [Abstract] [Full Text] [Related]

  • 4. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G, Zhu J, Liu F, Yang Y.
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [Abstract] [Full Text] [Related]

  • 5. miR-145-5p Modulates Gefitinib Resistance by Targeting NRAS and MEST in Non-Small Cell Lung Cancer.
    Yu C, Li B, Wang J, Zhang Z, Li S, Lei S, Wang Q.
    Ann Clin Lab Sci; 2021 Sep; 51(5):625-637. PubMed ID: 34686504
    [Abstract] [Full Text] [Related]

  • 6. A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.
    Fan D, Yang Y, Zhang W.
    BMC Pulm Med; 2022 Jan 07; 22(1):27. PubMed ID: 34996416
    [Abstract] [Full Text] [Related]

  • 7. HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer.
    Tang X, Jiang J, Zhu J, He N, Tan J.
    Mol Genet Genomics; 2019 Feb 07; 294(1):85-93. PubMed ID: 30196354
    [Abstract] [Full Text] [Related]

  • 8. MiR-142-5p reverses the resistance to gefitinib through targeting HOXD8 in lung cancer cells.
    Zhu W, Wang JP, Meng QZ, Zhu F, Hao XF.
    Eur Rev Med Pharmacol Sci; 2020 Apr 07; 24(8):4306-4313. PubMed ID: 32373967
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L, Sun S, Shi J, Cao F, Han X, Chen Z.
    Tumour Biol; 2017 Jun 07; 39(6):1010428317697579. PubMed ID: 28631574
    [Abstract] [Full Text] [Related]

  • 10. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p.
    Li J, Song Y, Yu B, Yu Y.
    DNA Cell Biol; 2020 Jul 07; 39(7):1256-1263. PubMed ID: 32456459
    [Abstract] [Full Text] [Related]

  • 11. Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis.
    Yu B, Zheng L, Tang H, Wang W, Lin Y.
    Mol Med Rep; 2021 Oct 07; 24(4):. PubMed ID: 34396444
    [Abstract] [Full Text] [Related]

  • 12. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
    Gao Y, Fan X, Li W, Ping W, Deng Y, Fu X.
    Biochem Biophys Res Commun; 2014 Mar 28; 446(1):179-86. PubMed ID: 24582749
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
    Ren P, Gong F, Zhang Y, Jiang J, Zhang H.
    Tumour Biol; 2016 Mar 28; 37(3):3215-25. PubMed ID: 26432332
    [Abstract] [Full Text] [Related]

  • 14. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
    Rao C, Miao X, Zhao G, Zhang C, Shen H, Dong C, Yang M.
    Biomed Pharmacother; 2019 Jun 28; 114():108662. PubMed ID: 30999114
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells.
    Chandimali N, Huynh DL, Zhang JJ, Lee JC, Yu DY, Jeong DK, Kwon T.
    Cancer Gene Ther; 2019 Sep 28; 26(9-10):292-304. PubMed ID: 30341415
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
    Pei K, Zhu JJ, Wang CE, Xie QL, Guo JY.
    Eur Rev Med Pharmacol Sci; 2016 Nov 28; 20(22):4697-4704. PubMed ID: 27906433
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
    Yu S, Qin X, Chen T, Zhou L, Xu X, Feng J.
    Anticancer Drugs; 2017 Sep 28; 28(8):852-860. PubMed ID: 28723865
    [Abstract] [Full Text] [Related]

  • 18. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B, Wang R, Liu H.
    Biomed Res Int; 2021 Sep 28; 2021():6622342. PubMed ID: 34055989
    [Abstract] [Full Text] [Related]

  • 19. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J, Zhang Y, Shen W, Fu R, Ding Z, Zhen Y, Wan Y.
    Biomed Pharmacother; 2019 Sep 28; 117():109058. PubMed ID: 31176168
    [Abstract] [Full Text] [Related]

  • 20. miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells.
    Zhang W, Lin J, Wang P, Sun J.
    J Drug Target; 2017 Feb 28; 25(2):125-131. PubMed ID: 27633093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.